Arkolith/Insider Trading/BDTX/Form 4

Velleca Mark A.

PRESIDENT & CEO, DirectorBlack Diamond Therapeutics, Inc. (BDTX) · full profile →Form 4 · filed Jan 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 21, 2026Grant(A)600K—$0600K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001706847-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML